Do You Draw Up Nph Or Regular Insulin First
Short-acting insulin formulation
A vial of regular human insulin | |
Clinical data | |
---|---|
Trade names | Humulin R, Novolin R, Actrapid, others[1] [2] |
Other names | insulin injection (soluble),[2] neutral insulin,[2] regular human insulin, human insulin (regular) |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682611 |
License data |
|
Routes of administration | subcutaneous, intramuscular, intravenous[2] |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Onset of action | 30 minutes |
Duration of action | 8 hours |
Identifiers | |
CAS Number |
|
ChemSpider |
|
UNII |
|
Regular insulin, also known as neutral insulin and soluble insulin is a type of short-acting insulin.[2] It is used to treat type 1 diabetes, type 2 diabetes, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states.[3] It is also used along with glucose to treat high blood potassium levels.[4] Typically it is given by injection under the skin, but may also be used by injection into a vein or muscle.[2] Onset of effect is typically in 30 minutes and it typically lasts for 8 hours.[3]
The common side effect is low blood sugar.[3] Other side effects may include pain or skin changes at the sites of injection, low blood potassium, and allergic reactions.[3] Use during pregnancy is relatively safe for the baby.[3] Regular insulin can be made from the pancreas of pigs or cows.[2] Human versions can be made either by modifying pig versions or recombinant technology.[2]
Insulin was first used as a medication in Canada by Charles Best and Frederick Banting in 1922.[5] It is on the World Health Organization's List of Essential Medicines.[6] In 2017, it was the 73rd most commonly prescribed medication in the United States, with more than ten million prescriptions.[7] [8] Versions are also available mixed with longer-acting versions of insulin, such as NPH insulin.[2]
Medical uses [edit]
Regular insulin is used for the long-term management of diabetes.[3] It is the treatment of choice for the two diabetic emergencies diabetic ketoacidosis and hyperosmolar hyperglycemic states.[3] It may also be used in combination with glucose to lower potassium levels in those with hyperkalemia.[4]
Side effects [edit]
Side effects may include: low blood sugar levels, skin reactions at the site of injection and low potassium levels among others.[3]
Manufacture [edit]
Humulin, one brand name for a group of biosynthetic human insulin products, is synthesized in a laboratory strain of Escherichia coli bacteria which has been genetically altered with recombinant DNA to produce biosynthetic human insulin. Humulin R consists of zinc-insulin crystals dissolved in a clear fluid.
Formulations [edit]
It is sold by many manufacturers in a number of different forms.
By Eli Lilly these include:
- Humulin R (REGULAR human insulin injection [rDNA origin]) is a short-acting insulin that has a relatively short duration of activity as compared with other insulins.
- Humulin R Regular U-500 (Concentrated) insulin human injection, USP (rDNA Origin) is a stronger concentration (500 units/mL) of Humulin R.
- Humulin 70/30 (70% human insulin isophane suspension, 30% human insulin injection [rDNA origin]) is a mixture insulin. It is an intermediate-acting insulin combined with the onset of action of Humulin
- Humulin 50/50 (50% human insulin isophane suspension, 50% human insulin injection [rDNA origin]) is a mixture insulin. It is an intermediate-acting insulin combined with the onset of action of Humulin R.
In UK these include:[9]
- Actrapid
- Humulin S
- Insuman Rapid
References [edit]
- ^ "insulin regular human (OTC) – Humulin R, Novolin R". Archived from the original on 16 December 2014. Retrieved 1 December 2014.
- ^ a b c d e f g h i British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. p. 464472. ISBN9780857111562.
- ^ a b c d e f g h American Society of Health-System Pharmacists. "Insulin Human". drugs.com. Archived from the original on 22 October 2016. Retrieved 1 January 2017.
- ^ a b Mahoney, BA; Smith, WA; Lo, DS; Tsoi, K; Tonelli, M; Clase, CM (18 April 2005). "Emergency interventions for hyperkalaemia". The Cochrane Database of Systematic Reviews (2): CD003235. doi:10.1002/14651858.CD003235.pub2. PMC6457842. PMID 15846652.
- ^ Fleishman JL, Kohler JS, Schindler S (2009). Casebook for The Foundation a Great American Secret. New York: PublicAffairs. p. 22. ISBN978-0-7867-3425-2. Archived from the original on 18 January 2017.
- ^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ^ "The Top 300 of 2020". ClinCalc . Retrieved 11 April 2020.
- ^ "Insulin Human - Drug Usage Statistics". ClinCalc . Retrieved 11 April 2020.
- ^ "Human Insulin - Types, Production, Action, History". Retrieved 17 November 2017.
External links [edit]
- "Insulin regular". Drug Information Portal. U.S. National Library of Medicine.
- "Insulin". Drug Information Portal. U.S. National Library of Medicine.
- "Insulin [Injection], biphasic". Drug Information Portal. U.S. National Library of Medicine.
Do You Draw Up Nph Or Regular Insulin First
Source: https://en.wikipedia.org/wiki/Regular_insulin
Posted by: martinezdiente.blogspot.com
0 Response to "Do You Draw Up Nph Or Regular Insulin First"
Post a Comment